The role of tissue kallikrein 1 in hematopoietic stem cell transplant-associated thrombotic microangiopathy |
Baylor College of Medicine / Sarah Sartain, MD |
Innovation Grants |
2024 |
Texas |
MYCN-induced molecular clock disruption and metabolic rewiring drive neuroblastoma |
Baylor College of Medicine / Lingzhi Li, PhD |
Young Investigator Grants |
2024 |
Texas |
Development of allogeneic off-the-shelf gamma delta T cell product for pediatric AML |
Baylor College of Medicine / Norihiro Watanabe, PhD |
Innovation Grants |
2024 |
Texas |
DMG: From SWI/SNF’s role in cholesterol biosynthesis to new therapeutic opportunities |
Board of Trustees of the Leland Stanford Junior University / Capucine Van Rechem, PhD |
Innovation Grants |
2024 |
California |
Development of CAR-T therapy for Ewing sarcoma using zebrafish in vivo models |
Children’s Hospital Los Angeles / James Amatruda, MD/PhD |
Innovation Grants |
2024 |
California |
Development of CAR-T therapy for Ewing sarcoma using zebrafish in vivo models |
Children’s Hospital Los Angeles / James Amatruda, MD/PhD |
Innovation Grants |
2024 |
California |
Unraveling GABAergic interneuron-like lineage in H3G34-mutant hemispheric high-grade gliomas: their impact on network formation and invasion |
Dana-Farber Cancer Institute / Gustavo Alencastro Veiga Cruzeiro, PhD |
Young Investigator Grants |
2024 |
Massachusetts |
Investigating the impact of osteosarcoma genetic lesions on bone differentiation |
Dana-Farber Cancer Institute / James Morrow, MD/PhD |
Young Investigator Grants |
2024 |
Massachusetts |
Exploiting a Novel DNA Repair Defect in Ewing Sarcoma |
Dana-Farber Cancer Institute / Shuhei Asada, MD/PhD |
Young Investigator Grants |
2024 |
Massachusetts |
Targeting the immunosuppressive effects of Myc-hyperactivation in high-risk osteosarcoma |
Emory University / Jason Yustein, MD/PhD |
Innovation Grants |
2024 |
Georgia |